Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Abbott launches Panbio COVID-19 and flu self-test across Canada


Onchilles reports early systemic activity with intratumoral N17350 in Phase I/II trial


mNEXSPIKE associated with lower COVID-19 hospitalisation risk than Comirnaty in older adults


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

ICH Q3E Impurity Guidelines: Assessment and Control of Extractractables and Leachables for Pharmaceuticals and Biologics.

Presented by Jason Creasey, Managing Director at Maven E&L Ltd, Piet Christiaens, PhD, Scientific Director and Philippe Verlinde, Ph.D. Ir. Senior Scientist - Study Director at Nelson Labs
14th September 2022


Harmonized Manufacturing Network For Sterility Assurance

Presented by Frederic Ayers, Advisor, Global Quality Systems at Eli Lilly and Company
06th February 2023


Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics at Novartis and Beate Kern, Product Manager at NanoTemper Technologies
27th September 2018


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia